Place : United States, San Jose
Contact Person:Ashutos Swain
Description:The globalization of the pharmaceutical supply chain has resulted in the increased use of Contract Manufacturing Organizations (CMOs). The use of CMOs provides many benefits; however, it also presents unique compliance risks, particularly since operations are not under your direct control. Compliance risks are highlighted by FDA Warning Letter trends, the majority of which are related to serious cGMP compliance and data integrity issues at foreign CMO sites.
Deadline for abstracts/proposals : 15th August 2021
Organized By :Complianceonline
Keynote Speakers :
Check the event website for more details.